Husu, E., Hove, H.
, Farholt, S., Bille, M., Tranebjaerg, L.
, Vogel, I. & Kreiborg, S. (2012).
Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome.
Clinical Genetics,
83(2), 125-134.
https://doi.org/10.1111/j.1399-0004.2012.01884.x
Hvid, M., Johansen, C., Deleuran, B., Kemp, K.
, Deleuran, M. & Vestergaard, C. (2012).
Inflammation induced barrier functions in atopic dermatitis.
Allergo Journal, (5), 77-80. Article 96.
Hvilsom, C.
, Qian, Y., Bataillon, T., Li, Y.
, Mailund, T., Sallé, B., Carlsen, F., Li, R., Zheng, H., Jiang, T.
, Jiang, H., Jin, X.
, Munch, K., Hobolth, A., Siegismund, H. R., Wang, J. & Schierup, M. H. (2012).
Extensive X-linked adaptive evolution in central chimpanzees.
Proceedings of the National Academy of Sciences (PNAS).
https://doi.org/10.1073/pnas.1106877109
Ishima, Y., Hara, M.
, Kragh-Hansen, U., Inoue, A., Suenaga, A., Kai, T., Watanabe, H., Otagiri, M. & Maruyama, T. (2012).
Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models.
Journal of Controlled Release,
164, 1-7.
Ishima, Y., Hoshino, H., Shinagawa, T., Watanabe, K., Akaike, T., Sawa, T.
, Kragh-Hansen, U., Kai, T., Watanabe, H., Maruyama, T. & Otagiri, M. (2012).
S-Guanylation of Human Serum Albumin is a Unique Posttranslational Modification and Results in a Novel Class of Antibacterial Agents.
Journal of Pharmaceutical Sciences,
101, 3222-3229.
Ishima, Y., Chen, D., Fang, J., Maeda, H., Minomo, A.
, Kragh-Hansen, U., Kai, T., Maruyama, T. & Otagiri, M. (2012).
S-Nitrosated Human Serum Albumin Dimer is not only a Novel Anti-Tumor Drug but also a Potentiator for Anti-Tumor Drugs with Augmented EPR Effects.
Bioconjugate Chemistry,
23, 264-271.
Iwao, Y., Ishima, Y., Yamada, J., Noguchi, T.
, Kragh-Hansen, U., Mera, K., Honda, D., Suenaga, A., Maruyama, T. & Otagiri, M. (2012).
Quantitative Evaluation of the Role of Cysteine and Methionine Residues in the Antioxidant Activity of Human Serum Albumin Using Recombinant Mutants.
IUBMB Life,
64, 450-454.
Jansakul, C., Tachanaparuksa, K.
, Mulvany, M. J. & Sukpondma, Y. (2012).
Relaxant mechanisms of 3, 5, 7, 30, 40-pentamethoxyflavone on isolated human cavernosum.
European Journal of Pharmacology,
691, 235-244.
Jayaprakash, R. R.
, Rajkumar, A. P., Nandyal, M., Kurian, S. & Jacob, K. S. (2012).
Dissociative stupor, mutism and amnesia in a young man.
Indian Journal of Psychiatry,
54(2), 198-9.
https://doi.org/10.4103/0019-5545.99545
Jelen, S., Gena, P.
, Lebeck, J., Rojek, A., Praetorius, J., Frøkiaer, J., Fenton, R. A., Nielsen, S., Calamita, G.
& Rützler, M. (2012).
Aquaporin-9 and urea transporter-A gene deletions affect urea transmembrane passage in murine hepatocytes.
A J P: Gastrointestinal and Liver Physiology (Online),
303(11), G1279-87.
https://doi.org/10.1152/ajpgi.00153.2012
Jendle, J.
, Christensen, J. H., Kvistgaard, H., Gregersen, N. & Rittig, S. (2012).
Late-onset familial neurohypophyseal diabetes insipidus due to a novel mutation in the AVP gene.
Clinical Endocrinology,
77, 586–592.
https://doi.org/10.1111/j.1365-2265.2012.04417.x
Jensen, M. G., Søndergaard, H. S., Stecher, C., Bibby, B. M., Møller, N., Bøtker, H. E., Hansen, S. B.
, Gjedde, A., Rungby, J. & Brock, B. (2012).
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
Journal of Clinical Endocrinology and Metabolism,
97(7), E1165-9.
https://doi.org/10.1210/jc.2011-3456
Jensen, M. G., Egefjord, L., Lerche, S., Vang, K.
, Bibby, B. M., Holst, J. J.
, Mengel, A., Møller, N., Rungby, J., Brock, B. & Gjedde, A. (2012).
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.
Journal of Cerebral Blood Flow and Metabolism,
32(12), 2146-52.
https://doi.org/10.1038/jcbfm.2012.118
Jensen, K. M., Melchjorsen, J., Dagnaes-Hansen, F., Sørensen, U. B. S., Laursen, R. R., Østergaard, L. J., Søgaard, O. S. & Tolstrup, M. (2012).
Timing of Toll-like receptor 9 agonist administration in pneumococcal vaccination impacts both humoral and cellular immune responses as well as nasopharyngeal colonization in mice.
Microcosm - I I I,
80(5), 1744-52.
https://doi.org/10.1128/IAI.00079-12
Jeppesen, J. V., Kristensen, S. G., Nielsen, M. E., Humaidan, P., Dal Canto, M., Fadini, R., Schmidt, K.
, Ernst, E. & Yding Andersen, C. (2012).
LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles.
Journal of Clinical Endocrinology and Metabolism,
97(8), E1524-31.
https://doi.org/10.1210/jc.2012-1427
Johannesson, T. G., Søgaard, O. S., Tolstrup, M., Petersen, M. S., Jensen, J. M. B., Østergaard, L. J. & Erikstrup, C. (2012).
The impact of B-cell perturbations on pneumococcal conjugate vaccine response in HIV-infected adults.
P L o S One,
7(7), e42307.
https://doi.org/10.1371/journal.pone.0042307